Inventor · disambiguated record
Heeoon Han
Also filed as: HAN HEEOON
2 granted patents·10 pending applications·5 citations·filing 2019–2025
44Inventor score
Files withINCYTE CORP12
Top patents by PatentIndex Score
12 records- 0188US11168089B2Fused pyrimidine derivatives as A2A / A2B inhibitorsINCYTE CORP·Filed 2019·Granted Nov 9, 2021·5 cites·36 claims
- 0276US2025034153A1Triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0375US2025313567A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2025·Application pending·0 cites
- 0473US2023124485A1Triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 0569US2025188073A1Tricyclic compounds as inhibitors of krasINCYTE CORP·Filed 2024·Application pending·0 cites
- 0667US2025084063A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0763US2025084087A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0863US2021061809A1Triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 0960US11873304B2Fused pyrimidine derivatives as A2A/A2B inhibitorsINCYTE CORP·Filed 2021·Granted Jan 16, 2024·0 cites·44 claims
- 1060US2019292188A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2019·Application pending·0 cites
- 1158US2021269434A1Tricyclic compounds as inhibitors of krasINCYTE CORP·Filed 2021·Application pending·0 cites
- 1239US2025243208A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heeoon Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →